• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2026, Vol. 28 ›› Issue (5): 726-732.DOI: 10.3969/j.issn.1671-2587.2026.05.009

Previous Articles     Next Articles

Preliminary Study on Identification of Red Blood Cell Unexpected Antibody Specificity Based on the "Three-Step Method" Identification Process

DING Mengyuan1, LIN Hao2, FENG Jinzhe3, WEN Huiyan4   

  1. 1Blood Group Reference Laboratory, Suzhou Blood Center, Suzhou 215006;
    2Department of Transfusion Medicine, Suzhou Maternal and Child Health Hospital, Suzhou 215006;
    3Department of Transfusion Medicine, Suzhou Municipal Hospital, Suzhou 215006;
    4Department of Transfusion Medicine, The Second Affiliated Hospital of Soochow University, Suzhou 215006
  • Received:2026-09-01 Revised:2026-09-23 Online:2026-10-20 Published:2026-11-11

Abstract: Objective To analyze the major causes of positive unexpected antibody screening with negative or nonspecific identification, and to develop a workflow that improves specific alloantibody detection while reducing unnecessary referrals. Methods We examined antibody screening-positive specimens referred to a reference laboratory from November 25, 2024 to February 5, 2026. Of 562 specimens completing antibody identification, 119 (21.17%) yielded negative or nonspecific results, and 50 were selected for detailed etiological investigation. Four specimens with known antibody specificity were sent to four hospital laboratories for multicenter comparison with screening cells and anti-human globulin cards unified to control variables. Seven sera, including one weak anti-E positive control, were tested weekly to monitor agglutination intensity of the same batch of screening cells stored from weeks 5 to 15; data were analyzed using a mixed-effects model (REML) and Kaplan-Meier method. Based on these findings, a three-step identification protocol was piloted in two hospitals for 2 months. Seventeen referred specimens (7 compliant) formed the intervention group, and 12 specimens from the same period of the previous year served as historical controls to compare the detection rate of specific antibodies. Results Among the 50 specimens, the main causes were false-positive screening cells, saline-reactive antibodies, weak alloantibodies and antibodies of undetermined specificity (AUS); HLA antibodies were detected in some cases. In the multicenter comparison, cold-reactive anti-M was detected only in laboratory 1, and after unified use of the anti-human globulin card, neither cold agglutinin nor anti-M was detected. Agglutination intensity of the 7 monitored specimens increased significantly with prolonged storage [F (8,42)=11.35, P<0.000 1], and was significantly higher at weeks 12 (P=0.000 5), 13 (P=0.030 9), 14 (P<0.000 1) and 15 (P=0.025 7) than at week 5. All 7 specimens developed false-positive events within 15 weeks (median, 12 weeks). During the pilot, specific antibody detection was 100% (7/7) in the compliant group versus 70% (7/10) in the non-compliant group(absolute risk difference 30%, 95%CI: 2%—58%, P=0.237). Weak-positive specimens were more frequent in the intervention group than in historical controls (64.7%) vs 16.7%, P=0.021). Conclusion sStorage-related false positivity of screening cells is an important modifiable cause of nonspecific antibody identification, especially after ≥12 weeks of storage. The three-step protocol can improve specific antibody detection. Incorporating screening cell functional status into routine quality control may reduce false-positive interference.

Key words: Antibody screening, Antibody identification, False-positive reactions, Storage time, Antibody screening cells

CLC Number: